title: Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes.
authors.affiliation: Mellen Center for MS Treatment and Research, Cleveland, Ohio 44195, USA. rudickr@ccf.org
authors.forename: Richard A
authors.initials: RA
authors.lastname: Rudick
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Fisher
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001284:Atrophy / Q000517:prevention & control; D001921:Brain / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000893:Anti-Inflammatory Agents